Youhong Liu

The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells

Youxiang Hou, Qianling Zhu, Zheng Li et al. · Cell Death and Disease · 2017 · 128 citations · Full text

Medicine, Oncology, Pharmacology +17

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

Linglong Yin, Youhong Liu, Yuchong Peng et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 127 citations · Full text

Medicine, Oncology, Pharmacology +16

UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications

Yingxue Gao, Yijun Liu, Youhong Liu et al. · Cancer Letters · 2021 · 77 citations

Life Sciences, Molecular Biology, Oncology +17

Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low‐dose arsenite‐induced cell proliferation

Youhong Liu, Janet M. Hock, Con Sullivan et al. · Journal of Cellular Biochemistry · 2010 · 63 citations

Medicine, Oncology, Toxicology +17

Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition

Xiaohui Yu, Youhong Liu, Linglong Yin et al. · Oncogene · 2018 · 63 citations · Full text

Medicine, Oncology, Carcinogenesis +15